Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Royalty Pharma
Pharma
BeOne bags $885M in Royalty deal on Amgen's Imdelltra
BeOne is monetizing its stake in Amgen’s first-in-class lung cancer drug Imdelltra as competition brews in the DLL3 field.
Angus Liu
Aug 25, 2025 10:34am
For 2nd time in three months, Syndax wins FDA nod for a new drug
Nov 18, 2024 11:09am
Syndax strikes $350M funding deal with Royalty Pharma
Nov 5, 2024 10:50am
In a first, FDA approves Servier's Voranigo in low-grade gliomas
Aug 6, 2024 5:25pm
Teva taps Royalty to bankroll long-acting schizophrenia drug
Nov 13, 2023 11:40am
Royalty commits up to $1.5B for most of PTC's Evrysdi royalties
Oct 19, 2023 11:13am
